Related Experiment Video

Updated: Mar 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

896

The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target

André E S Simões1, Cecília M P Rodrigues1, Pedro M Borralho1

  • 1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal.

Drug Discovery Today
|June 21, 2016
PubMed

Insights

The MEK5/ERK5 pathway, a less-studied mitogen-activated protein kinase (MAPK) subfamily, plays a key role in cancer development and therapy resistance. Targeting MEK5/ERK5 offers promising new strategies for human cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase (MAPK) pathways are crucial in cancer, but the MEK5/ERK5 subfamily is less understood.
  • MEK5/ERK5 signaling is implicated in normal cell growth, survival, and differentiation, and increasingly recognized in cancer hallmarks.

Purpose of the Study:

  • To explore the role of MEK5/ERK5 signaling in the onset and progression of various cancers.
  • To highlight the potential clinical relevance of targeting MEK5/ERK5 pathways in cancer therapy.

Main Methods:

  • Literature review and analysis of existing research on MEK5/ERK5 signaling in cancer.
  • Examination of evidence linking MEK5/ERK5 to oncogenic pathways and therapy resistance.

Main Results:

  • MEK5/ERK5 signaling contributes to multiple cancer hallmarks and mediates oncogene effects.
  • Evidence suggests MEK5/ERK5 signaling is involved in developing resistance to cancer therapies.

Conclusions:

  • The MEK5/ERK5 pathway is a significant contributor to cancer development and progression.
  • Inhibiting MEK5/ERK5 signaling presents a potential therapeutic strategy for human cancers.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K